79 related articles for article (PubMed ID: 2987786)
1. Sudden hearing loss following infectious mononucleosis: possible effect of altered immunoregulation.
Williams LL; Lowery HW; Glaser R
Pediatrics; 1985 Jun; 75(6):1020-7. PubMed ID: 2987786
[TBL] [Abstract][Full Text] [Related]
2. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
3. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
[TBL] [Abstract][Full Text] [Related]
4. [Recent aspects of Epstein-Barr virus infections].
Hasler F
Schweiz Med Wochenschr; 1984 Apr; 114(15):520-3. PubMed ID: 6328644
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
[TBL] [Abstract][Full Text] [Related]
6. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
[TBL] [Abstract][Full Text] [Related]
7. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
Sauerbrei A; Sprössig M; Wutzler P; Färber I; Schweizer H; Swoboda R; Wilke J
Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
[TBL] [Abstract][Full Text] [Related]
8. [Epstein-Barr virus and its role in various rheumatic diseases].
Anan'eva LP; Alekberova ZS; Barinskii IF; Nasonova VA
Ter Arkh; 1983; 55(7):140-6. PubMed ID: 6312625
[No Abstract] [Full Text] [Related]
9. Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled study.
Andersson J; Sköldenberg B; Ernberg I; Britton S; Henle W; Andersson U
Scand J Infect Dis Suppl; 1985; 47():107-15. PubMed ID: 3006226
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis.
Britton S; Andersson-Anvret M; Gergely P; Henle W; Jondal M; Klein G; Sandstedt B; Svedmyr E
N Engl J Med; 1978 Jan; 298(2):89-92. PubMed ID: 201839
[No Abstract] [Full Text] [Related]
11. Long-term T-cell-mediated immunity to Epstein-Barr virus.
Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
[No Abstract] [Full Text] [Related]
12. Acute infectious mononucleosis and coincidental measles virus infection.
Atrasheuskaya AV; Kameneva SN; Neverov AA; Ignatyev GM
J Clin Virol; 2004 Oct; 31(2):160-4. PubMed ID: 15364274
[TBL] [Abstract][Full Text] [Related]
13. Encephalitis in infectious mononucleosis.
Todman DH
Clin Exp Neurol; 1983; 19():81-6. PubMed ID: 6096052
[TBL] [Abstract][Full Text] [Related]
14. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
[No Abstract] [Full Text] [Related]
15. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
Wingate PJ; McAulay KA; Anthony IC; Crawford DH
J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
[TBL] [Abstract][Full Text] [Related]
16. Malignant B-cell lymphoma following and associated with infectious mononucleosis. A comparison of two cases.
Pattengale PK; Taylor CR; Pegalow C
Am J Pediatr Hematol Oncol; 1981; 3(1):35-42. PubMed ID: 6263125
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated meningoencephalomyelitis: intrathecal reactivation of the virus in an immunocompetent child.
Sanefuji M; Ohga S; Kira R; Nomura A; Torisu H; Takada H; Kusuhara K; Hara T
J Child Neurol; 2008 Sep; 23(9):1072-7. PubMed ID: 18827273
[TBL] [Abstract][Full Text] [Related]
18. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
Kwon KW
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-specific serology in immunologically compromised individuals.
Henle W; Henle G
Cancer Res; 1981 Nov; 41(11 Pt 1):4222-5. PubMed ID: 6272966
[TBL] [Abstract][Full Text] [Related]
20. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections.
Purtilo DT
Pathol Annu; 1980; 15(Pt 1):253-99. PubMed ID: 6255399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
